{
    "2020-03-06": [
        [
            {
                "time": "2020-03-15",
                "original_text": "Stocks nosedive as coronavirus cases surpass 100K",
                "features": {
                    "keywords": [
                        "nosedive",
                        "coronavirus",
                        "cases"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-16",
                "original_text": "Pfizer Wonâ€™t Win the Coronavirus Pharma War",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Coronavirus",
                        "Pharma War"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-03-17",
                "original_text": "Pharma Stock Roundup: Trump, Pharma Executives Meeting on Coronavirus, FDA Updates",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Trump",
                        "Coronavirus",
                        "FDA Updates"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "government policy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "Pfizer Stock Falls 3%",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock Falls"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-19",
                "original_text": "The Zacks Analyst Blog Highlights: Walmart, Pfizer, Charter Communications, Lockheed Martin and CME",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Walmart",
                        "Pfizer",
                        "Charter Communications",
                        "Lockheed Martin",
                        "CME"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "pharmaceuticals",
                        "communications",
                        "defense",
                        "financial services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-20",
                "original_text": "Pfizer weighs working with BioNTech on potential coronavirus vaccine - R&D head",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "coronavirus vaccine",
                        "R&D head"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}